Skip to content
healthcare.dev

Otrexup

NDC 54436-022, methotrexate, injection, solution, from Antares Pharma, Inc..

Product NDC
54436-022
Status
Listed
Labeler
Antares Pharma, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54436-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • METHOTREXATE22.5 mg/.4mL

Pharmacologic classes

Folate Analog Metabolic Inhibitor [EPC]; Folic Acid Metabolism Inhibitors [MoA]

Package NDCNDC-11Package
54436-022-01544360022011 SYRINGE in 1 CARTON (54436-022-01) / .4 mL in 1 SYRINGE
54436-022-03544360022031 SYRINGE in 1 CARTON (54436-022-03) / .4 mL in 1 SYRINGE
54436-022-04544360022044 SYRINGE in 1 CARTON (54436-022-04) / .4 mL in 1 SYRINGE (54436-022-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9ab8ce16-f7de-41d4-a4c8-1c742621b6d5

Use it

Look up 54436-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54436-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54436-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.